Advances and Surgical Considerations in the Treatment of Moyamoya Disease.

Moyamoya is a rare disorder that involves steno-occlusive arterial changes of the anterior circulation, along with proliferative development of basal arterial collaterals. It is either idiopathic (called moyamoya disease) or the result of a specific underlying condition such as atherosclerosis, radiation therapy, or sickle cell disease (called moyamoya syndrome or phenomenon). In recent years, numerous insights into and advances in the understanding, evaluation, and management of moyamoya patients have occurred. This article briefly reviews the spectrum of moyamoya conditions and then provides a synopsis of numerous recent investigations that shed light on various aspects of the disease, including its clinical characteristics, natural history, underlying pathology, imaging, surgical techniques, and long-term patient outcome. MMD, moyamoya disease; STA, superficial temporal ischemic

[1]  Grant W. Mallory,et al.  Moyamoya Disease in a Primarily White, Midwestern US Population: Increased Prevalence of Autoimmune Disease , 2013, Stroke.

[2]  C. Derdeyn,et al.  Intracranial atherosclerotic disease associated with moyamoya collateral formation: histopathological findings. , 2013, Journal of neurosurgery.

[3]  D. Geng,et al.  Whole-Brain CT Perfusion and CT Angiography Assessment of Moyamoya Disease before and after Surgical Revascularization: Preliminary Study with 256-Slice CT , 2013, PloS one.

[4]  R. Du,et al.  The natural history of Moyamoya in a North American adult cohort , 2013, Journal of Clinical Neuroscience.

[5]  Rong Wang,et al.  Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  M. Maltenfort,et al.  Moyamoya disorder in the United States. , 2012, Neurosurgery.

[7]  W. Joo,et al.  Prevalence and Epidemiological Features of Moyamoya Disease in Korea , 2012, Journal of cerebrovascular and endovascular neurosurgery.

[8]  T. Noguchi,et al.  Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging. , 2011, European journal of radiology.

[9]  G. Steinberg,et al.  Neurosurgical Advances in the Treatment of Moyamoya Disease , 2011, Stroke.

[10]  S. Gazal,et al.  Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. , 2011, American journal of human genetics.

[11]  Dong-Seok Kim,et al.  Natural history and progression factors of unilateral moyamoya disease in pediatric patients , 2011, Child's Nervous System.

[12]  R. Guzman,et al.  Intraoperative Blood Flow Analysis of Direct Revascularization Procedures in Patients with Moyamoya Disease , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  A. Hata,et al.  A genome-wide association study identifies RNF213 as the first Moyamoya disease gene , 2011, Journal of Human Genetics.

[14]  V. Larrue,et al.  Correlation between cognitive impairment and cerebral hemodynamic disturbances on perfusion magnetic resonance imaging in European adults with moyamoya disease , 2010 .

[15]  R. Grubb,et al.  Clinical Features and Outcome in North American Adults With Idiopathic Basal Arterial Occlusive Disease Without Moyamoya Collaterals , 2010, Neurosurgery.

[16]  I. Nakagawa,et al.  Virtual surgical planning for superficial temporal artery to middle cerebral artery bypass using three-dimensional digital subtraction angiography , 2010, Acta Neurochirurgica.

[17]  Seung-Chyul Hong,et al.  Association of Thyroid Autoantibodies With Moyamoya-Type Cerebrovascular Disease: A Prospective Study , 2010, Stroke.

[18]  R. Scott,et al.  Moyamoya disease and moyamoya syndrome. , 2009, The New England journal of medicine.

[19]  H. Machado,et al.  Effect of multiple cranial burr hole surgery on prevention of recurrent ischemic attacks in children with moyamoya disease. , 2009, Neuropediatrics.

[20]  T. Tominaga,et al.  Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease. , 2009, Surgical neurology.

[21]  M. Marks,et al.  Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. , 2009, Journal of neurosurgery.

[22]  M. Elkind,et al.  Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article. , 2009, Journal of neurosurgery.

[23]  Moyamoya Phenomenon Secondary to Intracranial Atherosclerotic Disease: Diagnosis by 3T Magnetic Resonance Imaging , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[24]  H. Steiger,et al.  C-Port Flex-A-assisted automated anastomosis for high-flow extracranial-intracranial bypass surgery in patients with symptomatic carotid artery occlusion: a feasibility study. Clinical article. , 2009, Journal of neurosurgery.

[25]  J. Miller,et al.  Cerebral hemodynamics as a predictor of stroke in adult patients with moyamoya disease: a prospective observational study. , 2009, Neurosurgical focus.

[26]  P. Berlit,et al.  Moyamoya Disease in Europeans , 2008, Stroke.

[27]  E. Connolly,et al.  Radiographic and clinical predictors of hemodynamic insufficiency in patients with athero-occlusive disease. , 2008, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[28]  M. Chicoine,et al.  Automated, compliant, high-flow common carotid to middle cerebral artery bypass. , 2008, Journal of neurosurgery.

[29]  S. Lee,et al.  Moyamoya syndrome associated with systemic lupus erythematosus , 2008, Lupus.

[30]  K. Nozaki,et al.  “TARGET BYPASS”: A METHOD FOR PREOPERATIVE TARGETING OF A RECIPIENT ARTERY IN SUPERFICIAL TEMPORAL ARTERY‐TO‐MIDDLE CEREBRAL ARTERY ANASTOMOSES , 2008, Neurosurgery.

[31]  A. van der Zwan,et al.  Excimer laser-assisted nonocclusive anastomosis. An emerging technology for use in the creation of intracranial-intracranial and extracranial-intracranial cerebral bypass. , 2008, Neurosurgical focus.

[32]  T. Yoshimoto,et al.  Prevalence and Clinicoepidemiological Features of Moyamoya Disease in Japan: Findings From a Nationwide Epidemiological Survey , 2008, Stroke.

[33]  S. Kuroda,et al.  Novel epidemiological features of moyamoya disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[34]  R. Grubb,et al.  Clinical Features and Outcome in North American Adults With Moyamoya Phenomenon , 2006, Stroke.

[35]  D. Tirschwell,et al.  Moyamoya disease in Washington State and California , 2005, Neurology.

[36]  Peter Vajkoczy,et al.  Intraoperative control of extracranial-intracranial bypass patency by near-infrared indocyanine green videoangiography. , 2005, Journal of neurosurgery.

[37]  Douglas J. Fox,et al.  Moyamoya Disease in Adults: The Role of Cerebral Revascularization , 2005, Skull base : official journal of North American Skull Base Society ... [et al.].

[38]  S. Amin-Hanjani,et al.  The Cut Flow Index: An Intraoperative Predictor of the Success of Extracranial-Intracranial Bypass for Occlusive Cerebrovascular Disease , 2005, Neurosurgery.

[39]  S. Kuroda,et al.  Increased Expression of Hepatocyte Growth Factor in Cerebrospinal Fluid and Intracranial Artery in Moyamoya Disease , 2004, Stroke.

[40]  M. Fukui,et al.  A novel susceptibility locus for moyamoya disease on chromosome 8q23 , 2004, Journal of Human Genetics.

[41]  S. Miyamoto Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset--the Japan Adult Moyamoya Trial Group. , 2004, Neurologia medico-chirurgica.

[42]  H. Seol,et al.  Moyamoya Disease among Young Patients: Its Aggressive Clinical Course and the Role of Active Surgical Treatment , 2004, Neurosurgery.

[43]  Jodi,et al.  Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. , 2004, Journal of neurosurgery.

[44]  S. Kuroda,et al.  Sequence analysis and bioinformatics analysis of chromosome 17q25 in familial moyamoya disease , 2004, Child's Nervous System.

[45]  P. Huh,et al.  Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population. , 2003, Journal of Korean medical science.

[46]  J. Gosalakkal Moyamoya disease: a review. , 2002, Neurology India.

[47]  A. Yamaura,et al.  Long-term natural history of hemorrhagic moyamoya disease in 42 patients. , 2000, Journal of neurosurgery.

[48]  T. Sakaki,et al.  Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. , 2000, Journal of neurosurgery.

[49]  T. Yoshimoto,et al.  Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: An extensive follow-Up study. , 1999, Stroke.

[50]  M. Fukui,et al.  Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. , 1999, American journal of human genetics.

[51]  T. Yoshimoto,et al.  Effect of inhalational anesthesia on cerebral circulation in Moyamoya disease. , 1998, Journal of neurosurgical anesthesiology.

[52]  J. Grotta,et al.  Clinical features of moyamoya disease in the United States. , 1998, Stroke.

[53]  Kayoko Saito,et al.  Long-term outcomes of pediatric moyamoya disease monitored to adulthood. , 1998, Pediatric neurology.

[54]  D. Nam,et al.  Moyamoya disease in adults: characteristics of clinical presentation and outcome after encephalo-duro-arterio-synangiosis , 1997, Clinical Neurology and Neurosurgery.

[55]  M. Fukui,et al.  Clinical features of probable Moyamoya disease in Japan , 1997, Clinical Neurology and Neurosurgery.

[56]  K. Fujii,et al.  The efficacy of bypass surgery for the patients with hemorrhagic Moyamoya disease , 1997, Clinical Neurology and Neurosurgery.

[57]  M. Fukui,et al.  Epidemiological features of Moyamoya disease in Japan: findings from a nationwide survey , 1997, Clinical Neurology and Neurosurgery.

[58]  S. Peerless Risk factors of Moyamoya disease in Canada and the USA , 1997, Clinical Neurology and Neurosurgery.

[59]  K. Takase,et al.  Transcranial Doppler ultrasonography in patients with Moyamoya disease , 1997, Clinical Neurology and Neurosurgery.

[60]  E. Y. Kim,et al.  Natural history of Moyamoya disease: comparison of activity of daily living in surgery and non surgery groups , 1997, Clinical Neurology and Neurosurgery.

[61]  K. Houkin,et al.  Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. , 1997, Stroke.

[62]  A. Takahashi,et al.  Angiogenic factors in moyamoya disease. , 1996, Stroke.

[63]  M. Aoyagi,et al.  Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. , 1996, Stroke.

[64]  H. Topka,et al.  Progressive cerebral occlusive disease after radiation therapy. , 1995, Stroke.

[65]  H. Hoshi,et al.  Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[66]  H. Adams,et al.  Cerebral infarction due to moyamoya disease in young adults. , 1988, Stroke.

[67]  Y. Fukuyama,et al.  Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of willis (“Moyamoya” disease) in children , 1985, Brain and Development.

[68]  K. Hasuo,et al.  Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. , 1985, Pediatric neurology.

[69]  N. Lenn,et al.  Moyamoya and other causes of stroke in patients with Down syndrome. , 1985, Pediatric neurology.

[70]  N. Kodama,et al.  Moyamoya disease‐‐a review. , 1983, Stroke.

[71]  J. Woolliscroft,et al.  Familial occurrence of intracranial arterial occlusive disease (Moyamoya) in neurofibromatosis , 1980, Clinical genetics.

[72]  J. Parker,et al.  Dilated Episcleral Arteries — a Significant Physical Finding in Assessment of Patients with Cerebrovascular Insufficiency Cerebrovascular Disease in Sickle Cell Anemia: a Clinical, Pathological and Radiological Correlation , 2022 .

[73]  A Takaku,et al.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. , 1969, Archives of neurology.

[74]  R. Donaghy,et al.  Microangeional surgery and its techniques. , 1968, Progress in brain research.